Cytokinetics, Incorporated

Cytokinetics, Incorporated

CYTK
Cytokinetics, IncorporatedUS flagNASDAQ
81.11
USD
+2.00
- -
10.09BMarket Cap

Cytokinetics, Incorporated (CYTK) Stock Split History

Learn about Cytokinetics, Incorporated's most recent 1-for-6 basis stock split on June 25, 2013. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Cytokinetics, Incorporated's most recent stock split

Split Date: 2013-06-25
Split Ratio: 1:6
Price Before Split: $2.01
Price After Split: $0.33

Developer API

Get CYTK split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/CYTK

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 6.00 times fewer shares (a 1:6 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Cytokinetics, Incorporated's stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2013-06-251:6Yes$2.01$0.33

About Cytokinetics, Incorporated

Company overview and industry information

Cytokinetics, Incorporated (CYTK) operates in the Biotechnology industry. The recent 1-for-6 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Cytokinetics, Incorporated Summary

Last updated: 7/22/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.